View in EDS

Cure Models: What is Meant by a Survival 'Plateau', and Do Experts Agree on What Constitutes One?

Saved in:
Bibliographic Details
Title: Cure Models: What is Meant by a Survival 'Plateau', and Do Experts Agree on What Constitutes One?
Authors: Jackson D; Statistical Innovation Group, AstraZeneca, Cambridge, UK. daniel.jackson1@astrazeneca.com., Sweeting M; Statistical Innovation Group, AstraZeneca, Cambridge, UK., Hettle R; Health Technology Assessment and Modelling Science, AstraZeneca, Cambridge, UK., Yu B; Statistical Innovation Group, AstraZeneca, Cambridge, UK., Hawkins N; Health Economics and Health Technology Assessment, School of Health and Wellbeing, University of Glasgow, Glasgow, UK., Abrams K; Department of Statistics and Warwick Medical School, University of Warwick, Coventry, UK., Baker R; Salford Business School, University of Salford, Salford, UK.
Source: PharmacoEconomics [Pharmacoeconomics] 2026 Jan; Vol. 44 (1), pp. 73-82. Date of Electronic Publication: 2025 Oct 14.
Publication Type: Journal Article
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41085859
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cure Models: What is Meant by a Survival 'Plateau', and Do Experts Agree on What Constitutes One?
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jackson+D%22">Jackson D</searchLink>; Statistical Innovation Group, AstraZeneca, Cambridge, UK. daniel.jackson1@astrazeneca.com.<br /><searchLink fieldCode="AU" term="%22Sweeting+M%22">Sweeting M</searchLink>; Statistical Innovation Group, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Hettle+R%22">Hettle R</searchLink>; Health Technology Assessment and Modelling Science, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Yu+B%22">Yu B</searchLink>; Statistical Innovation Group, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Hawkins+N%22">Hawkins N</searchLink>; Health Economics and Health Technology Assessment, School of Health and Wellbeing, University of Glasgow, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Abrams+K%22">Abrams K</searchLink>; Department of Statistics and Warwick Medical School, University of Warwick, Coventry, UK.<br /><searchLink fieldCode="AU" term="%22Baker+R%22">Baker R</searchLink>; Salford Business School, University of Salford, Salford, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229212404%22">PharmacoEconomics</searchLink> [Pharmacoeconomics] 2026 Jan; Vol. 44 (1), pp. 73-82. <i>Date of Electronic Publication: </i>2025 Oct 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9212404 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-2027 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211707690%22">11707690 </searchLink><i>NLM ISO Abbreviation: </i>Pharmacoeconomics <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41085859
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40273-025-01546-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 73
    Titles:
      – TitleFull: Cure Models: What is Meant by a Survival 'Plateau', and Do Experts Agree on What Constitutes One?
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jackson D
      – PersonEntity:
          Name:
            NameFull: Sweeting M
      – PersonEntity:
          Name:
            NameFull: Hettle R
      – PersonEntity:
          Name:
            NameFull: Yu B
      – PersonEntity:
          Name:
            NameFull: Hawkins N
      – PersonEntity:
          Name:
            NameFull: Abrams K
      – PersonEntity:
          Name:
            NameFull: Baker R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2026 Jan
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1179-2027
          Numbering:
            – Type: volume
              Value: 44
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: PharmacoEconomics
              Type: main
ResultId 1